(May 28, 2020, 2:30 PM EDT) -- PHILADELPHIA — A Pennsylvania federal judge on May 26 said plaintiffs’ claims that generic drug manufacturer Sandoz Inc. failed to warn a patient about the pulmonary toxicity of the heart drug amiodarone are preempted by the state’s learned intermediary doctrine in granting summary judgment for the defendant (Caroline Polt, et al. v. Sandoz, Inc., No. 16-2362, E.D. Pa., 2020 U.S. Dist. LEXIS 91237)....